Locations:
Abu Dhabi|Canada|Florida|London|Nevada|Ohio|
Gray gradientGray gradient
Cleveland Clinic icon
Consult QD logo
Search IconSearch

Tag: psoriatic diseases

Researchers standing in laboratory
June 19, 2024/Rheumatology & Immunology/Research

Novel Drug Targets and Early Biomarkers of Psoriatic Diseases

Husni Lab focuses on transforming management and treatment

Psoriatic arthritis
November 21, 2023/Rheumatology & Immunology/Rheumatic Diseases

Psoriatic Arthritis: Unlocking the Age Factor

Older Psoriasis Patients May Experience Quicker Transition

Virtual coaching
November 7, 2023/Rheumatology & Immunology/Research

Boosting Mental Health Access for Patients with Psoriatic Disease

E-coaching program is tailored for those with the disease

17-RHE-1348-Husni-Hero-Image-650x450pxl
October 17, 2019/Basic & Translational Science

Targeting Tumor Necrosis Factor Pathways in Psoriatic Diseases: The Next Step

Husni lab recently funded by NIH-NIAMS

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

16-RHE-1500-Husni-650×450
May 19, 2016/Rheumatology & Immunology/Research

Asymmetric Dimethylarginine as a Novel Biomarker for Cardiovascular Risk in Psoriatic Diseases

A new, precise biomarker for CV risk in psoriatic disease?

15-RHE-2814-Husni-Image-650x450pxl
February 16, 2016/Rheumatology & Immunology/Research

New Research Lab Brings an Interdisciplinary Approach to Psoriatic Diseases

Early focus will be selective TNF-α receptor inhibition

BackPage 1 of 1Next

Advertisement

Ad